Finally, the prognostic value of RIP140 was significantly associated with good prognosis in low GLUT3 expression group but not in high GLUT3 expression group in colon and stomach cancers, suggesting that a reduced level of GLUT3 could reflect RIP140 anti-tumor activity in other types of cancer (Supplementary Fig. 6b). This evidence concerns the gene SLC2A3 and neoplasm.